ATRO Stock Analysis: Astronics | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 3.205m USD | 12M Return: 147.4% | US0464331083 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 49.4M
Qual. Beats: 1
Rev. Trend: -46.8%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Astronics Corporation (NASDAQ: ATRO) is a U.S.-based supplier that designs and manufactures specialized products for the aerospace, defense, and electronics industries, operating across the United States, North America, Asia, Europe, and South America. The company runs two segments: Aerospace, which provides lighting, safety, power generation, distribution, seat motion, structures, and avionics products to aircraft OEMs, airlines, and the U.S. Department of Defense; and Test Systems, which builds automated test equipment and training/simulation devices for aerospace, defense, communications, and mass transit customers.
As a tier-1 supplier in the Aerospace & Defense sector, Astronics typically operates within long product certification cycles tied to airframe programs, with revenue concentrated among a small number of commercial and military OEMs. The company was incorporated in 1968, is headquartered in East Aurora, New York, and has been listed on NASDAQ since 1984. It is classified as a mid-cap stock within the GICS Industrials sector, Aerospace & Defense sub-industry.
- Boeing and Airbus production rate increases boost Aerospace revenue
- Defense avionics and military lighting demand supports margins
- Test Systems segment revenue pressured by program timing and customer mix
| Net Income: 79.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.50 > 1.0 |
| NWC/Revenue: 34.22% < 20% (prev 34.13%; Δ 0.09% < -1%) |
| CFO/TA 0.14 > 3% & CFO 103.3m > Net Income 79.1m |
| Net Debt (388.2m) to EBITDA (113.2m): 3.43 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago 27.96% < -2% |
| Gross Margin: 32.54% > 18% (prev 25.09%; Δ 7.44% > 0.5%) |
| Asset Turnover: 133.9% > 50% (prev 127.2%; Δ 6.62% > 0%) |
| Interest Coverage Ratio: 8.52 > 6 (EBIT TTM 93.5m / Interest Expense TTM 11.0m) |
| A: 0.42 (Total Current Assets 485.7m - Total Current Liabilities 163.4m) / Total Assets 760.8m |
| B: 0.28 (Retained Earnings 216.7m / Total Assets 760.8m) |
| C: 0.13 (EBIT TTM 93.5m / Avg Total Assets 703.8m) |
| D: 0.35 (Book Value of Equity 198.2m / Total Liabilities 562.6m) |
| Altman-Z'' = 4.97 = AAA |
| DSRI: 1.07 (Receivables 228.9m/187.3m, Revenue 942.1m/822.9m) |
| GMI: 0.77 (GM 25.09% / 32.54%) |
| AQI: 0.97 (AQ_t 0.17 / AQ_t-1 0.17) |
| SGI: 1.14 (Revenue 942.1m / 822.9m) |
| TATA: -0.03 (NI 79.1m - CFO 103.3m) / TA 760.8m) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of September 10, 2026, the stock is trading at USD 75.60 with a total of 432,213 shares traded. Over the past week, the price has changed by +3.58%, over one month by +0.19%, over three months by +11.98% and over the past year by +147.39%.
Current recommended Stop Loss: 69.10 (which is 8.6% or 1.7 ATR below the current price).
Astronics has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold ATRO.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 89.6 | 18.5% |
P/E Trailing = 40.2865
P/E Forward = 27.1739
P/S = 3.4025
P/B = 15.823
P/EG = 1.4638
Revenue TTM = 942.1m USD
EBIT TTM = 93.5m USD
EBITDA TTM = 113.2m USD
Long Term Debt = 334.5m USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.93m USD (from shortTermDebt, last quarter)
Debt = 397.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 44.2m
Net Debt = 388.2m USD (calculated: Debt 397.2m - CCE 9.02m)
Enterprise Value = 3.59b USD (3.21b + Debt 397.2m - CCE 9.02m)
Interest Coverage Ratio = 8.52 (Ebit TTM 93.5m / Interest Expense TTM 11.0m)
EV/FCF = 58.51x (Enterprise Value 3.59b / FCF TTM 61.4m)
FCF Yield = 1.71% (FCF TTM 61.4m / Enterprise Value 3.59b)
FCF Margin = 6.52% (FCF TTM 61.4m / Revenue TTM 942.1m)
Net Margin = 8.40% (Net Income TTM 79.1m / Revenue TTM 942.1m)
Gross Margin = 32.54% ((Revenue TTM 942.1m - Cost of Revenue TTM 635.6m) / Revenue TTM)
Gross Margin QoQ = 33.43% (prev 32.58%)
Tobins Q-Ratio = 4.72 (Enterprise Value 3.59b / Total Assets 760.8m)
Interest Expense / Debt = 2.76% (Interest Expense 11.0m / Debt 397.2m)
Taxrate = 4.17% (3.44m / 82.6m)
NOPAT = 89.6m (EBIT 93.5m * (1 - 4.17%))
Current Ratio = 2.97 (Total Current Assets 485.7m / Total Current Liabilities 163.4m)
Debt / Equity = 2.00 (Debt 397.2m / totalStockholderEquity, last quarter 198.2m)
Debt / EBITDA = 3.43 (Net Debt 388.2m / EBITDA 113.2m)
Debt / FCF = 6.32 (Net Debt 388.2m / FCF TTM 61.4m)
Total Stockholder Equity = 152.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.24% (Net Income 79.1m / Total Assets 760.8m)
RoE = 51.97% (Net Income TTM 79.1m / Total Stockholder Equity 152.2m)
RoCE = 19.22% (EBIT 93.5m / Capital Employed (Equity 152.2m + L.T.Debt 334.5m))
RoIC = 15.08% (NOPAT 89.6m / Invested Capital 594.4m)
WACC = 9.57% (E(3.21b)/V(3.60b) * Re(10.43%) + D(397.2m)/V(3.60b) * Rd(2.76%) * (1-Tc(0.04)))
Discount Rate = 10.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.10 | Cagr: 13.69%
[DCF] Terminal Value 74.12% ; FCFF base≈51.3m ; Y1≈58.8m ; Y5≈86.5m
[DCF] Fair Price = 18.91 (EV 1.07b - Net Debt 388.2m = Equity 682.8m / Shares 36.1m; r=9.57% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.30 | # QB: 1
Revenue Correlation: -46.82 | Revenue CAGR: -5.71% | SUE: 2.46 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.78 | Chg30d=+31.82% | Revisions=+29% | Analysts=1
EPS current Year (2026-12-31): EPS=2.72 | Chg30d=+11.61% | Revisions=+25% | GrowthEPS=+62.4% | GrowthRev=+19.8%
EPS next Year (2027-12-31): EPS=3.15 | Chg30d=+19.40% | Revisions=+17% | GrowthEPS=+15.7% | GrowthRev=+7.8%
[Analyst] Revisions Ratio: +36% (up=6, down=2)